SpringWorks Therapeutics, Inc. (SWTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 3.18B |
| Enterprise Value | 2.75B |
| Trailing P/E | 21.09 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 107.21 |
| Price/Book (mrq) | 5.61 |
| Enterprise Value/Revenue | 104.12 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.84 |
| 52-Week Change 3 | 33.19% |
| S&P500 52-Week Change 3 | 29.31% |
| 52 Week High 3 | 53.92 |
| 52 Week Low 3 | 18.00 |
| 50-Day Moving Average 3 | 45.60 |
| 200-Day Moving Average 3 | 35.71 |
Share Statistics
| Avg Vol (3 month) 3 | 942.48k |
| Avg Vol (10 day) 3 | 621.73k |
| Shares Outstanding 5 | 74.09M |
| Implied Shares Outstanding 6 | 74.09M |
| Float 8 | 72.45M |
| % Held by Insiders 1 | 2.27% |
| % Held by Institutions 1 | 109.95% |
| Shares Short (Apr 30, 2024) 4 | 10.01M |
| Short Ratio (Apr 30, 2024) 4 | 12.63 |
| Short % of Float (Apr 30, 2024) 4 | 16.37% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 13.52% |
| Shares Short (prior month Mar 28, 2024) 4 | 10.66M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -447.16% |
Management Effectiveness
| Return on Assets (ttm) | -36.63% |
| Return on Equity (ttm) | -63.12% |
Income Statement
| Revenue (ttm) | 26.45M |
| Revenue Per Share (ttm) | 0.40 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -357.1M |
| Net Income Avi to Common (ttm) | -339.07M |
| Diluted EPS (ttm) | -5.15 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 436.58M |
| Total Cash Per Share (mrq) | 5.9 |
| Total Debt (mrq) | 6.56M |
| Total Debt/Equity (mrq) | 1.16% |
| Current Ratio (mrq) | 6.85 |
| Book Value Per Share (mrq) | 7.67 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -239.91M |
| Levered Free Cash Flow (ttm) | -120.9M |
© 2024 Yahoo. All rights reserved.